Average Co-Inventor Count = 5.34
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celgene Avilomics Research, Inc. (19 from 44 patents)
2. Celgene Car LLC (9 from 44 patents)
3. Avila Therapeutics, Inc. (2 from 5 patents)
30 patents:
1. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
2. 11292772 - Salts of an epidermal growth factor receptor kinase inhibitor
3. 10828300 - Substituted 2,4-diaminopyrimidines as kinase inhibitors
4. 10596172 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
5. 10570099 - Salts of an epidermal growth factor receptor kinase inhibitor
6. 10010548 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
7. 10005738 - Salts of an epidermal growth factor receptor kinase inhibitor
8. 9987276 - Substituted 2,4-diaminopyrimidines as kinase inhibitors
9. 9604936 - Besylate salt of a BTK inhibitor
10. 9549927 - Heteroaryl compounds and uses thereof
11. 9540335 - Salts of an epidermal growth factor receptor kinase inhibitor
12. 9415049 - Heteroaryl compounds and uses thereof
13. 9409921 - 2,4-disubstituted pyrimidines as kinase inhibitors
14. 9393246 - 4,6-disubstituted pyrimidines as kinase inhibitors
15. 9296737 - Substituted 2,4-diaminopyrimidines as kinase inhibitors